0001179110-19-006685.txt : 20190524 0001179110-19-006685.hdr.sgml : 20190524 20190524170201 ACCESSION NUMBER: 0001179110-19-006685 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190523 FILED AS OF DATE: 20190524 DATE AS OF CHANGE: 20190524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blaser Brian J CENTRAL INDEX KEY: 0001492289 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 19855167 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 edgar.xml FORM 4 - X0306 4 2019-05-23 0 0000001800 ABBOTT LABORATORIES ABT 0001492289 Blaser Brian J 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400 0 1 0 0 Executive Vice President Common shares without par value 2019-05-23 4 M 0 165000 34.94 A 295745 D Common shares without par value 2019-05-23 4 M 0 175164 39.12 A 470909 D Common shares without par value 2019-05-23 4 M 0 53163 47.00 A 524072 D Common shares without par value 2019-05-23 4 M 0 56735 38.40 A 580807 D Common shares without par value 2019-05-23 4 S 0 450062 75.5201 D 130745 D Option (right to buy) 34.94 2019-05-23 4 M 0 165000 0 D 2016-02-15 2023-02-14 Common shares 165000 0 D Option (right to buy) 39.12 2019-05-23 4 M 0 175164 0 D 2017-02-21 2024-02-20 Common shares 175164 0 D Option (right to buy) 47.00 2019-05-23 4 M 0 53163 0 D 2018-02-20 2025-02-19 Common shares 53163 120000 D Option (right to buy) 38.40 2019-05-23 4 M 0 56735 0 D 2019-02-19 2026-02-18 Common shares 56735 300000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.50 to $75.70, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Jessica H. Paik, by power of attorney for Brian J. Blaser 2019-05-24